Equities analysts expect Syros Pharmaceuticals Inc (NASDAQ:SYRS) to report $420,000.00 in sales for the current quarter, according to Zacks. Four analysts have issued estimates for Syros Pharmaceuticals’ earnings. The lowest sales estimate is $400,000.00 and the highest is $450,000.00. Syros Pharmaceuticals reported sales of $380,000.00 during the same quarter last year, which would suggest a […]
